FLEX MARKETING, a dynamic new independent agency built to modernize the approach to healthcare marketing, officially launches today. Its agile, innovative model is ideally suited to address the ...

Fintech is one of Africa's strongest services-driven industries, with the market projected to reach $3.3 billion by 2025 (Statista, 2024).

West Pharmaceutical Services (WST) stock plummeted 38% on Thursday, making it the biggest decliner in the S&P 500. The sharp ...

BofA lowered the firm’s price target on West Pharmaceutical (WST) to $285 from $355 and keeps a Buy rating on the shares after the company ...

Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...

At its present level of around $200, WST stock is trading at just 5.1x trailing revenue, compared to its five-year average ...

We recently compiled a list of the Weak Earnings, Outlook Drag Shares of These 10 Firms on Thursday. In this article, we are ...

What Happened? Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) fell 34.9% in the afternoon ...

Discover key insights from West Pharmaceutical Services' Q4 2024 earnings call, highlighting growth in GLP-1 elastomers, biologics, and HVP components.

Shares of West Pharmaceutical Services Inc. WST slipped 2.64% to $321.55 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.95% ...

West Pharmaceutical Services, Inc. has a 12 month low of $265.00 and a 12 month high of $409.72. The firm has a market cap of $23.48 billion, a price-to-earnings ratio of 48.11, a P/E/G ratio of ...

West Pharmaceutical Services WST is scheduled to release fourth-quarter 2024 results on Feb. 13, before the opening bell. In the last reported quarter, the company delivered an earnings beat of 22 ...